Charles River helps bring novel cell therapy products to market via a strategic and consultative-based approach. With great consideration given to scientific and regulatory concerns, our cell therapy safety program designs integrate both safety and efficacy aspects as well as mitigate risk factors inherent in developing novel cellular therapies. In the design of your program, our multidisciplinary team will accommodate the novel properties of your cell therapy product, including complications of cross-species reactivity.
Cell Therapy Product Development and Testing Services Offered:
Visit our Regulatory Document Library to access regulatory documents on stems cells and gene therapy from the FDA, EMA, MHLW, WHO and more.
Related Cellular Therapeutic Information
- Cellular Therapeutics Products and Services
- Researcher #200 – Nonclinical, Cell-Based Therapy Testing: A Comprehensive Service (Available only in The Source℠. Click here to log in or click here to register.)
- Webinar Replay - Translational Toxicology Programs for Cellular Therapies (Available only in The Source℠. Click here to log in or click here to register.)
- Webinar Replay - Cell Therapy Preclinical Safety Programs: Cost-Effective Approaches to Biodistribution Employing Advanced Technologies (Available only in The Source℠. Click here to log in or click here to register.)